<DOC>
	<DOCNO>NCT02112877</DOCNO>
	<brief_summary>This multi-center , prospective , single arm , non-randomized study evaluate safety efficacy Veniti Vici™ Venous Stent System relation pre-defined Objective Performance goal . The follow-up period 60 month .</brief_summary>
	<brief_title>VIRTUS : An Evaluation Veniti Vici™ Venous Stent System Patients With Chronic Iliofemoral Venous Outflow Obstruction</brief_title>
	<detailed_description>The objective prospective study ass safety efficacy Veniti Vici™ Venous Stent System achieve patency target venous lesion patient clinically significant chronic non-malignant obstruction iliofemoral venous outflow tract .</detailed_description>
	<criteria>Inclusion Criteria PreProcedure Criteria : Age ≥ 18 year Willing capable comply followup evaluation specify time Able willing provide write informed consent prior studyspecific procedure Presence unilateral , clinically significant , chronic nonmalignant obstruction common femoral vein , external iliac vein , common iliac vein , combination thereof , define ≥50 % reduction target vessel lumen diameter ( measure venogram procedure ) Clinically significant venous obstruction define meet least one follow clinical indicator : Clinical severity class CEAP classification ≥3 VCSS Pain Score ≥2 Negative pregnancy test female childbearing potential Intention stent target lesion Veniti Vici Venous Stent Exclusion Criteria PreProcedure Criteria : Presence history clinically significant pulmonary embolus within 6 month prior enrollment . Venous obstruction extend inferior vena cava ( IVC ) Contralateral disease common femoral vein , external iliac vein , common iliac vein , combination thereof plan treatment within 30 day subject enrollment Life expectancy &lt; 12 month Female childbearing potential pregnant plan become pregnant duration clinical study Uncontrolled active coagulopathy OR know , uncorrectable bleed diathesis follow definition : Uncorrected INR ≥2.0 aPTT ≥1.5 X normal local lab value Platelet count &lt; 80,000 Uncorrected hemoglobin ≤ 9 g/dL Patients estimate glomerular filtration rate ( eGFR ) &lt; 30 mL/min . In patient diabetes mellitus , eGFR &lt; 45 mL/min . Known hypersensitivity nickel titanium Contrast agent allergy manage adequately premedication Intended concurrent thrombolysis thrombectomy procedure OR intend plan ( within 30 day ) adjuvant procedure creation temporary arteriovenous fistula , placement IVC filter , endovenectomy saphenous vein ablation Current recent ( within 30 day ) active participation another drug device clinical trial ( Participation observational study acceptable . ) Patient judged poor candidate primary investigator Patients prior surgical endovascular procedure target vessel [ Note : Patients catheterdirected mechanical thrombolysis target vessel DVT least 3 month ( 90 day ) prior VIRTUS index procedure may include trial . ] Exclusion Criteria IntraProcedural Criteria : Patients lesion traverse guide wire . Patients obstruction extends inferior vena cava level less trochanter . Patients whose vein diameter within limit state current Instructions Use determine venogram . Patients meet venogram binary stenosis definition , determine treat physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>iliofemoral vein</keyword>
	<keyword>venous</keyword>
	<keyword>venous obstruction</keyword>
</DOC>